Top compounds associated with response to RP11-318A15.7


Feature Type Standardized
Nominal ANOVA
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.094 0.01
mRNA YM-155 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA Teniposide CTRPv2 pan-cancer AAC -0.098 0.02
mRNA RAF265 CTRPv2 pan-cancer AAC -0.097 0.02
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.02
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.08 0.02
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.071 0.03
Download CSV